Natriuretic peptides are regulatory autacoids in the mammalian myocardium whose
functions, mediated via particulate guanylyl cyclase/cGMP, may include cytoprotection …

B-type natriuretic peptide (BNP) has been reported to be released from the myocardium
during ischemia. We hypothesized that BNP mediates cardioprotection during ischemia …

In both experimental and clinical myocardial ischaemia, release of BNP occurs rapidly from
ventricular myocardium, prompting speculation that the early activation of the natriuretic …

The therapy for acute myocardial infarction (AMI) has been improved; yet, AMI remains a
major cause of death and heart failure in industrialized countries. B-type natriuretic peptide …

We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion
reduces infarction in rabbit hearts and whether protection is related to activation of protein …

Background: Natriuretic peptides have actions likely to ameliorate cardiac dysfunction. B-
type natriuretic peptide (BNP) is indicated as treatment for decompensated cardiac failure …

Objectives To investigate the relationship between brain natriuretic peptide (BNP) plasma
concentration levels and the clinical course, mortality and success of left ventricular …

BACKGROUND: Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate
cyclase, has been found to protect against reoxygenation-induced hypercontracture in …

BACKGROUND: Brain natriuretic peptide (BNP) has recently been shown to have a
cardioprotective effect in animal models of myocardial ischemia-reperfusion (IR) injury. We …

Background We have demonstrated that brain natriuretic peptide (BNP) is a cardiac
hormone predominantly synthesized in and secreted from the ventricle. We have also …